SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
SEC Accession No. 0000950123-10-062310
Filing Date
2010-06-29
Accepted
2010-06-29 16:43:50
Documents
7

Document Format Files

Seq Description Document Type Size
1 SC TO-I/A y85282sctoviza.htm SC TO-I/A 27047
2 EX-99.A.1.C y85282exv99waw1wc.htm EX-99.A.1.C 7356
3 EX-99.A.1.D y85282exv99waw1wd.htm EX-99.A.1.D 7519
4 EX-99.A.5.C y85282exv99waw5wc.htm EX-99.A.5.C 9889
5 EX-99.A.5.D y85282exv99waw5wd.htm EX-99.A.5.D 9978
7 GRAPHIC y85282y8528201.gif GRAPHIC 2991
8 filename8.htm CORRESP 21070
  Complete submission text file 0000950123-10-062310.txt   89344
Mailing Address 41 PINELAWN ROAD MELVILLE NY 11747
Business Address 41 PINELAWN ROAD MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Filed by) CIK: 0000729922 (see all company filings)

IRS No.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-I/A
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 41 PINELAWN ROAD MELVILLE NY 11747
Business Address 41 PINELAWN ROAD MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Subject) CIK: 0000729922 (see all company filings)

IRS No.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-I/A | Act: 34 | File No.: 005-37954 | Film No.: 10924365
SIC: 2835 In Vitro & In Vivo Diagnostic Substances